NADAL® Nuclear Matrix Protein 22 Test
$155.91
- Qualitative detection of NMO22 in urine samples
- Rapid test for bladder cancer screening
- Test result can be read after approx. 15 minutes
- Simple visual interpretation without additional devices
- 10 test cassettes and 10 disposable pipettes
NADAL® Nuclear Matrix Protein 22 Test
The NADAL® Nuclear Matrix Protein 22 (NMP22) Test from nal von Minden is a reliable in-vitro immunoassay for the qualitative detection of Nuclear Mitotic Apparatus Protein (NuMA) in urine. This professional rapid test offers doctors a simple and hygienic method for bladder cancer screening and monitoring, with results available in approximately 15 minutes.
Product Details
- NADAL® Nuclear Matrix Protein 22 from nal von Minden
- Reliable and hygienic in-vitro immunoassay
- Qualitative detection of Nuclear Mitotic Apparatus Protein (NuMA)
- Professional rapid test for bladder cancer screening
- Applicable for monitoring as well
- Sample material: Urine
- Detected parameter: Nuclear Matrix Protein 22
- Results readable in about 15 minutes
- Simple visual interpretation without additional devices
- Includes integrated procedural control
- Storage at room temperature (2-30 °C)
- CE marked
- Includes 10 disposable pipettes and a user manual
- 10 tests
Performance Characteristics
To obtain data on diagnostic sensitivity and specificity, urine from 32 patients with biopsy-confirmed bladder cancer and 112 healthy individuals without bladder tumours was tested with the NADAL® Nuclear Matrix Protein 22 Test. The results are shown in the table below:
Reviews
There are no reviews yet.